These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6480290)
21. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae). Da Silva SL; Chaar Jda S; Yano T Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998 [TBL] [Abstract][Full Text] [Related]
22. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells. Olsson L; Kiger N; Kronstrom H Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655 [TBL] [Abstract][Full Text] [Related]
23. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Nakanishi H; Oguri K; Takenaga K; Hosoda S; Okayama M Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714 [TBL] [Abstract][Full Text] [Related]
24. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen. Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748 [TBL] [Abstract][Full Text] [Related]
25. Seminal ribonuclease inhibits tumor growth and reduces the metastatic potential of Lewis lung carcinoma. Laccetti P; Spalletti-Cernia D; Portella G; De Corato P; D'Alessio G; Vecchio G Cancer Res; 1994 Aug; 54(16):4253-6. PubMed ID: 8044766 [TBL] [Abstract][Full Text] [Related]
26. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549. Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z Oncology; 2006; 70(6):418-26. PubMed ID: 17245103 [TBL] [Abstract][Full Text] [Related]
27. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry. Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695 [TBL] [Abstract][Full Text] [Related]
28. Drug resistance and its counteraction by cyclosporin A in function of metastatic potential in the Lewis lung carcinoma system. Michowitz M; Dayan-Avidan G; Bar-Shira-Maymon B; Donin N; Leibovici J Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):551-60. PubMed ID: 8061572 [TBL] [Abstract][Full Text] [Related]
29. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice. Giraldi T; Sava G; Perissin L; Zorzet S Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994 [TBL] [Abstract][Full Text] [Related]
30. Effects of dimethyltriazenes combined with surgery and non-specific immunotherapy in mice bearing Lewis lung carcinoma lines. Sava G; Perissin L; Zorzet S; Tomasić J Anticancer Res; 1985; 5(3):301-5. PubMed ID: 4015044 [TBL] [Abstract][Full Text] [Related]
31. Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes. Sava G; Giraldi T; Lassiani L; Nisi C Cancer Treat Rep; 1982 Sep; 66(9):1751-5. PubMed ID: 7116350 [TBL] [Abstract][Full Text] [Related]
32. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159. Zupi G; Cavallari A; Greco C; Sacchi A Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181 [TBL] [Abstract][Full Text] [Related]
33. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin. Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050 [TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effect and mechanism of sulfate polysaccharide of algae on lung cancer]. Zhai ZG; Jiang HD; Qin XM; Wang C Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):97-100. PubMed ID: 14990183 [TBL] [Abstract][Full Text] [Related]
35. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. Talmadge JE; Fidler IJ J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200 [TBL] [Abstract][Full Text] [Related]
36. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity. Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985 [TBL] [Abstract][Full Text] [Related]
37. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide. Contessa AR; Bonmassar A; Giampietri A; Circolo A; Goldin A; Fioretti MC Cancer Res; 1981 Jun; 41(6):2476-82. PubMed ID: 7016315 [TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518 [TBL] [Abstract][Full Text] [Related]
39. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis. Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197 [TBL] [Abstract][Full Text] [Related]
40. Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes. Sava G; Zorzet S; Perissin L; Giraldi T; Lassiani L Cancer Chemother Pharmacol; 1988; 21(3):241-5. PubMed ID: 3359559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]